Atlas Trials

Open Label Phase I Dose Escalation Study With BAY1143572 in Patients With Advanced Cancer

Clinical trial NCT01938638 · COMPLETED

Trial details

NCT number
NCT01938638
Sponsor
Bayer
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Neoplasms
Start date
2013-09-26
Primary completion
2016-08-17
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.